T2 Biosystems (TTOO) Profit Metrics
Price: $1.82
Market Cap: $31.81M
Avg Volume: 174.70K
Market Cap: $31.81M
Avg Volume: 174.70K
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Profit Metrics Summary (Annual)
According to T2 Biosystems's latest annual financial reports:
- The company has reported a gross profit of -8.83M, indicating the amount earned after deducting the cost of goods sold (COGS) from revenue. The gross profit margin is -122.74%, with a year-over-year growth of -857.20%.
- T2 Biosystems's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -46.29M. The EBITDA margin stands at -643.60%, showing a growth of 16.54% compared to the previous year.
- The operating income, representing the profit from business operations before taxes and interest, stands at -47.15M. The operating margin is -655.54%, with a year-over-year growth of 15.05%.
- The net income, which shows the company's total earnings or profit after all expenses, is -50.08M. The net profit margin is -696.19%, demonstrating a growth of 20.98% from the previous year.
These metrics provide a comprehensive overview of T2 Biosystems's profitability and operational efficiency over the past year.
Gross Profit
$-8.83M
Gross Profit Margin (2023)
-122.74%
EBITDA
$-46.29M
EBITDA Margin
-643.60%
Operating Income (2023)
$-47.15M
Operating Margin
-655.54%
Net Income
$-50.08M
Net Profit Margin
-696.19%
Historical Gross Profit
Historical Gross Profit Margin
Historical Gross Profit Growth
Historical EBITDA
Historical EBITDA Margin
Historical EBITDA Growth
Historical Operating Income
Historical Operating Profit Margin
Historical Operating Income Growth
Historical Net Income
Historical Net Profit Margin
Historical Net Income Growth
T2 Biosystems Historical Profit Metrics
T2 Biosystems Historical Profits
The table below shows various profit metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | Gross Profit | Gross Profit Growth | Operating Income | Operating Income Growth | Net Income | Net Income Growth | EBITDA | EBITDA Growth |
|---|---|---|---|---|---|---|---|---|
| 2023 | $-8.83M | -857.20% | $-47.15M | 15.05% | $-50.08M | 20.98% | $-46.29M | 16.54% |
| 2022 | $1.17M | -84.15% | $-55.51M | -29.17% | $-63.37M | -18.46% | $-55.47M | -30.05% |
| 2021 | $7.36M | 333.49% | $-42.97M | -3.91% | $-53.49M | -8.71% | $-42.66M | -3.30% |
| 2020 | $-3.15M | 62.62% | $-41.36M | 20.56% | $-49.21M | 22.03% | $-41.29M | 20.06% |
| 2019 | $-8.43M | -71.86% | $-52.06M | -15.45% | $-63.11M | -23.38% | $-51.66M | -16.16% |
| 2018 | $-4.90M | 33.39% | $-45.09M | 16.27% | $-51.15M | 18.06% | $-44.47M | 12.08% |
| 2017 | $-7.36M | -163.68% | $-53.85M | -5.85% | $-62.43M | -13.91% | $-50.58M | 0.25% |
| 2016 | $-2.79M | -360.21% | $-50.88M | -17.28% | $-54.80M | -21.01% | $-50.71M | -17.04% |
| 2015 | $1.07M | 105.46% | $-43.38M | -41.40% | $-45.29M | -44.28% | $-43.32M | -41.26% |
| 2014 | $-19.66M | -34.04% | $-30.68M | -55.80% | $-31.39M | -52.30% | $-30.67M | -56.29% |
| 2013 | $-14.67M | -25.30% | $-19.69M | -34.39% | $-20.61M | -42.58% | $-19.62M | -42.92% |
| 2012 | $-11.71M | 0.00% | $-14.65M | 0.00% | $-14.46M | 0.00% | $-13.73M | 0.00% |